Isenberg Derek, Wong Stella C, Curtis John A
Department of Emergency Medicine, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Am J Emerg Med. 2008 Sep;26(7):840.e3-5. doi: 10.1016/j.ajem.2008.01.039.
Suboxone (buprenorphine/naloxone) is an oral medication used for the treatment of opiate dependence. Because of its mixed properties at the opiate receptors, buprenorphine has a ceiling on its euphoric effects. We report the first case of serotonin syndrome caused by buprenorphine and review other medications implicated in serotonin syndrome. A 54-year-old man on tricyclic antidepressants took an unprescribed dose of buprenorphine/naloxone. He presented to the emergency department with signs and symptoms of severe serotonin syndrome including clonus, agitation, and altered mental status. His agitation was not controlled with benzodiazepines and was electively intubated. At the recommendation of the toxicology service, cyproheptadine, a serotonin receptor antagonist, was administered with improvement in the patient's symptoms. Emergency physicians should be aware of the potential of buprenorphine/naloxone to trigger serotonin syndrome.
舒泊西汀(丁丙诺啡/纳洛酮)是一种用于治疗阿片类药物依赖的口服药物。由于丁丙诺啡在阿片受体上具有混合特性,其欣快作用有上限。我们报告了首例由丁丙诺啡引起的血清素综合征病例,并回顾了其他与血清素综合征有关的药物。一名服用三环类抗抑郁药的54岁男性服用了未开处方剂量的丁丙诺啡/纳洛酮。他因严重血清素综合征的体征和症状就诊于急诊科,包括阵挛、激动和精神状态改变。他的激动症状用苯二氮䓬类药物无法控制,遂进行了选择性插管。根据毒理学服务部门的建议,给予了血清素受体拮抗剂赛庚啶,患者症状有所改善。急诊医生应意识到丁丙诺啡/纳洛酮引发血清素综合征的可能性。